Abstract
An anonymous questionnaire to investigate non-compliance with recombinant human growth hormone (rhGH), its causes and correlation with growth response, was sent to 60 children with renal disease; 48% returned the questionnaires; 69% reported that they were concerned about their size and 83% reported being treated as younger than they were. Understanding of the purpose and administration of rhGH was good; 62% missed some rhGH injections, but there was no correlation with understanding or difficulty with the injections, concern regarding size or growth response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received December 13, 1996; received in revised form and accepted June 24, 1997
Rights and permissions
About this article
Cite this article
Rees, L. Compliance with growth hormone therapy in chronic renal failure and post transplant. Pediatr Nephrol 11, 752–754 (1997). https://doi.org/10.1007/s004670050383
Published:
Issue Date:
DOI: https://doi.org/10.1007/s004670050383